Advanced Cooling Therapy (ACT), a medical device manufacturing company, has received CE marking for its first product, the esophageal cooling device (ECD) to control patient temperature.
The product is now available to medical professionals in Europe. The ECD is a single use, fully-enclosed triple lumen system that is inserted into the esophagus to modulate and control patient temperature when clinically indicated.
Two lumens attach to existing temperature modulation equipment while a third lumen simultaneously allows gastric decompression and drainage. The ECD can be rapidly inserted by most trained health care professionals, in similar fashion to a standard gastric tube, and can be used to control patient temperature in the operating room, recovery room, emergency room, or ICU..
ACT president and co-founder Dr Erik Kulstad said: "The ECD is safe, easy to use, and cost-effective, and we look forward to commercialization in Europe with the CE marking."
Advanced Cooling Therapy’s novel technology platform provides improved methods to control patient temperature where clinically indicated using the esophageal environment.